TA

Tushar Ashok Raut

Active Director Director DIN 11999244
DIN 11999244 First appointment Oct 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Tushar Ashok Raut

Tushar Ashok Raut is a Director at Medicrick Pharma Private Limited (since 2026).

DIN 11999244
Primary Designation Director
First Appointment 12 Oct 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medicrick Pharma Private Limited U46497PN2026PTC261507
Director12 Oct 20262026Active

Directorship timeline

Open interactive timeline →
Medicrick Pharma Private Limited
Premium access

Shareholding and investment profile for Tushar Ashok Raut

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tushar Ashok Raut

Tushar Ashok Raut currently holds 1 directorship: Medicrick Pharma Private Limited (Director, since 12 Oct 2026).

Tushar Ashok Raut was first appointed on 12 Oct 2026 as Director at Medicrick Pharma Private Limited.

The current boards of Tushar Ashok Raut's companies include Ajit Deshmukh (Medicrick Pharma Private Limited), Tushar Govind Gadade (Medicrick Pharma Private Limited), Vishal Jayantilal Mehta (Medicrick Pharma Private Limited), Yogesh Bachukant Sisodia (Medicrick Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available